Abstract
Genetic susceptibility plays a major role in the etiology of Graves’ disease (GD). A recent study revealed that the A946T polymorphism (rs1990760) in interferon induced helicase (IFIH1) gene was a susceptible locus for GD. A case-control study in a Chinese population was undertaken, with 261 GD patients and 206 healthy subjects, to analyze the association of A946T polymorphism in IFIH1 gene with GD. In addition, the distribution of IFIH1 genotypes was investigated in subgroups according to the onset age and the Graves’ ophthalmopathy (GO). No significant differences in the allele and genotype frequencies for A946T polymorphism were found between GD patients and healthy controls (χ 2 = 2.834, P = 0.242; χ 2 = 1.127, P = 0.288). The genotype–phenotype correlation was not identified either. Therefore we were unable to find the association of A946T polymorphism of the IFIH1 gene with the development of GD in a Chinese population.
Similar content being viewed by others
References
A.P. Weetman, N. Engl. J. Med. 343, 1236–1248 (2000)
B. Vaidya, P. Kendall-Taylor, S.H. Pearce, J. Clin. Endocrinol. Metab. 87, 5385–5397 (2002)
T.H. Brix, K.O. Kyvik, K. Christensen, L. Hegedüs, T.H. Brix, K.O. Kyvik, K. Christensen, L. Hegedüs, T.H. Brix, K.O. Kyvik, K. Christensen, L. Hegedüs, J. Clin. Endocrinol. Metab. 86, 930–934 (2001)
P.J. Hunt, S.E. Marshall, A.P. Weetman, M. Bunce, J.I. Bell, J.A. Wass, K.I. Welsh, Clin. Endocrinol. (Oxf). 55, 491–499 (2001)
M.J. Simmonds, J.M. Howson, J.M. Heward, H.J. Cordell, H. Foxall, J. Carr-Smith, S.M. Gibson, N. Walker, Y. Tomer, J.A. Franklyn, J.A. Todd, S.C. Gough, Am. J. Hum. Genet. 76, 157–163 (2005)
T. Kouki, Y. Sawai, C.A. Gardine, M.E. Fisfalen, M.L. Alegre, L.J. DeGroot, J. Immunol. 165, 6606–6611 (2000)
T. Bednarczuk, Y. Hiromatsu, T. Fukutani, K. Jazdzewski, P. Miskiewicz, M. Osikowska, J. Nauman, Eur. J. Endocrinol. 148, 13–18 (2003)
M.R. Velaga, V. Wilson, C.E. Jennings, C.J. Owen, S. Herington, P.T. Donaldson, S.G. Ball, R.A. James, R. Quinton, P. Perros, S.H. Pearce, J. Clin. Endocrinol. Metab. 89, 5862–5865 (2004)
A. Skórka, T. Bednarczuk, E. Bar-Andziak, J. Nauman, R. Ploski, Clin. Endocrinol. (Oxf). 62, 679–682 (2005)
F.A. Houston, V. Wilson, C.E. Jennings, C.J. Owen, P. Donaldson, P. Perros, S.H. Pearce, Thyroid 14, 506–509 (2004)
E.M. Jacobson, E. Concepcion, T. Oashi, Y.A. Tomer, Endocrinology 146, 2684–2691 (2005)
H. Hiratani, D.W. Bowden, S. Ikegami, S. Shirasawa, A. Shimizu, Y. Iwatani, T. Akamizu, J. Clin. Endocrinol. Metab. 90, 2898–2903 (2005)
D.J. Smyth, J.D. Cooper, R. Bailey, S. Field, O. Burren, L.J. Smink, C. Guja, C. Ionescu-Tirgoviste, B. Widmer, D.B. Dunger, D.A. Savage, N.M. Walker, D.G. Clayton, J.A. Todd, Nat. Genet. 38, 617–619 (2006)
A. Sutherland, J. Davies, C.J. Owen, S. Vaikkakara, C. Walker, T.D. Cheetham, R.A. James, P. Perros, P.T. Donaldson, H.J. Cordell, R. Quinton, S.H. Pearce, J. Clin. Endocrinol. Metab. 92, 3338–3341 (2007)
E. Meylan, J. Tschopp, Mol. Cell. 22, 561–569 (2006)
M. Yoneyama, M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y.M. Loo, M. Gale, S. Akira, S. Yonehara, A. Kato, T. Fujita, J. Immunol. 175, 2851–2858 (2005)
I. Marinou, D.S. Montgomery, M.C. Dickson, M.H. Binks, D.J. Moore, D.E. Bax, A.G. Wilson, Res. Ther. 9, 1–5 (2007)
A.P. Weetman, A.M. McGregor, Endocr. Rev. 15, 788–830 (1994)
G. Wick, B. Grubeck-Loebenstein, K. Trieb, G. Kalischnig, A. Aguzzi, Int. Arch. Allergy Appl. Immunol. 199, 153–156 (1992)
T. Matsuda, M. Tomita, J.N. Uchihara, T. Okudaira, K. Ohshiro, T. Tomoyose, T. Ikema, M. Masuda, M. Saito, M. Osame, N. Takasu, T. Ohta, N. Mori, J. Clin. Endocrinol. Metab. 90, 5704–5710 (2005)
J.C. Mandac, S. Chaudhry, K.E. Sherman, Y. Tomer, Hepatology 43, 661–672 (2006)
W.M. Howell, M.J. Rose-Zerilli, J.M. Theaker, A.C. Bateman, Int. J. Immunogenet. 32, 367–373 (2005)
Y. Ban, T. Tozaki, M. Taniyama, M. Tomita, Y. Ban, Thyroid 15, 1115–1118 (2005)
L. Bartalena, C. Marcocci, M.L. Tanda, L. Manetti, E. Dell’Unto, M.P. Bartolomei, Ann. Intern. Med. 129, 632–635 (1998)
R.S. Bahn, Endocr. Pract. 1, 172–178 (1995)
C. Marcocci, L. Bartalena, F. Bogazzi, M. Panicucci, A. Pinchera, Acta. Endocrinol. (Copenh) 120, 473–478 (1989)
A.E. Heufelder, W. Joba, Strabismus 8, 101–111 (2000)
Acknowledgments
The present study would not have been possible without the participation of the patients and healthy volunteers. The study is supported by the grants from the National Nature Science Foundation of China (No. 30370666).
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors Ze-Fei Zhao and Bin Cui have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhao, ZF., Cui, B., Chen, HY. et al. The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves’ disease in Chinese population. Endocr 32, 143–147 (2007). https://doi.org/10.1007/s12020-007-9024-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-007-9024-z